24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Memic
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:40
Greece approves $750M rocket deal with Elbit amid negotiations for $3.5B Israeli air-defense systems
19:09
Intel VP: “We’re just not going to accept subpar products”
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
21:48
From textile recycling to autonomous vessels: The vision behind the Dream Team startups
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
3
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
4
Check Point raises $1.75 billion, potentially eyeing AI expansion
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news
Memic
3 stories about Memic
Surgical robotics startup Momentis cutting 60% of team one year after $1 billion SPAC fell through
08.05.23
|
Meir Orbach
Momentis, formerly Memic, which develops robotic-assisted surgery solutions, is laying off 70 of 120 employees
Israeli medical device company Memic to merge with SPAC at more than $1 billion valuation
13.08.21
|
Golan Hazani
Memic is set to merge with Nasdaq-traded MedTech Acquisition Corporation, with the combined company expected to hold approximately $360 million in cash
Israeli medical device company Memic raises $96 million to expand surgical robotic solution
12.04.21
|
Meir Orbach
The funding is set to primarily support commercialization of the Hominis surgical robot in the U.S. following FDA De Novo marketing authorization